Halozyme Therapeutics (HALO) Enterprise Value (2010 - 2026)
Halozyme Therapeutics (HALO) posted Enterprise Value of $8.7 billion for Q2 2026, up 56.1% from $5.57 billion a year earlier and up 18.4% from the prior quarter.
Halozyme Therapeutics (HALO) Enterprise Value (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Enterprise Value at Halozyme Therapeutics was $7.53 billion, up 111.6% year-over-year; for FY2025, it came in at $7.78 billion, up 47.1% from FY2024.
- Annual Enterprise Value shows a five-year compound annual growth rate of 7.3% (FY2020 to FY2025).
- In prior years, Halozyme Therapeutics' Enterprise Value was $5.29 billion in FY2024 (+21.7%), $4.35 billion in FY2023 (-40.6%), $7.33 billion in FY2022 (+52.5%) and $4.8 billion in FY2021 (-12.2%).
- The Q2 2026 figure stands as the highest quarterly Enterprise Value in data going back to Q2 2010.
- On a year-over-year basis, Enterprise Value has increased in each of the last four quarters, with growth averaging 29.4% over the last eight quarters.
- The strongest year-over-year quarter for Enterprise Value in the past five years was Q2 2026, with growth of 56.1%; the weakest was Q4 2023, with a decline of 40.6%.
- According to Business Quant data, Enterprise Value for the three prior quarters was $7.34 billion (Q1 2026), $7.78 billion (Q4 2025) and $7.92 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | Halozyme Therapeutics | 12.72 Bn | 11.33 Bn | 401.83 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.70 Bn |
| Mar 31, 2026 | 7.34 Bn |
| Dec 31, 2025 | 7.78 Bn |
| Sep 30, 2025 | 7.92 Bn |
| Jun 30, 2025 | 5.57 Bn |
| Mar 31, 2025 | 7.11 Bn |
| Dec 31, 2024 | 5.29 Bn |
| Sep 30, 2024 | 6.61 Bn |
| Jun 30, 2024 | 6.10 Bn |
| Mar 31, 2024 | 4.71 Bn |
| Dec 31, 2023 | 4.35 Bn |
| Sep 30, 2023 | 4.56 Bn |
| Jun 30, 2023 | 4.41 Bn |
| Mar 31, 2023 | 4.75 Bn |
| Dec 31, 2022 | 7.33 Bn |
| Sep 30, 2022 | 5.08 Bn |
| Jun 30, 2022 | 5.85 Bn |
| Mar 31, 2022 | 4.71 Bn |
| Dec 31, 2021 | 4.80 Bn |
| Sep 30, 2021 | 4.92 Bn |
Halozyme Therapeutics Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=HALO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();